NCT05830097 2024-08-26A Study of Bi-Ligand-Drug Conjugate CBP-1019 in Patients With Advanced Solid TumorsCoherent Biopharma (Hefei) Co., Ltd.Phase 1/2 Unknown260 enrolled
NCT03083743 2017-03-20A Phase III Trial of Recombinant Human Apo-2 Ligand for InjectionShanghai Gebaide Biotechnology Co., Ltd.Phase 3 Unknown417 enrolled